Search Results
Found 1 results
510(k) Data Aggregation
(109 days)
WiScope® Digital Cystoscope System is intended to be used by physicians to access, visualize, and perform procedures in the bladder and lower ureter. The instrument enables delivery and use of accessories such as biopsy forceps, laser fibers, graspers and retrieval baskets at a surgical site.
WiScope® Digital Cystoscope System is designed for physicians to access, visualize, and perform procedures in the bladder and lower ureter for diagnosis and treatment. This system includes a single-use digital cystoscope.
WiScope®Digital Cystoscope System has the same intended use to the predicate device. Both devices use the same CMOS image sensor technology, i.e., an CMOS image sensor at the scope tip, a back-end image/video processing system, and a cable connecting the CMOS sensor to the processing system. In addition, they have same mechanical functions, e.g., a handle with a deflection control and a two-way deflectable insertion tube.
WiScope®Single-Use Digital Flexible Cystoscope has the following 4 models:
OTU-C300S: Standard Deflection Model for OTU-C300 series
OTU-C300R: Reverse Deflection Model for OTU-C300 series
OTU-C310S: Standard Deflection Model for OTU-C310 series
OTU-C310R: Reverse Deflection Model for OTU-C310 series
Here's an analysis of the provided text regarding the acceptance criteria and the study that proves the device meets the acceptance criteria:
Based on the provided text, the submission is a 510(k) for the WiScope® Digital Cystoscope System. The core of this submission is to demonstrate substantial equivalence to a previously cleared device (K212202) rather than proving novel performance against specific clinical acceptance criteria. Therefore, the information typically found in a clinical study seeking to establish performance against acceptance criteria for a new device is largely absent.
Here's the breakdown of the information requested, based on the provided text:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly present a table of acceptance criteria for clinical performance with reported results in the same way a de novo device might. Instead, it relies on demonstrating that the proposed device is substantially equivalent to a predicate device (K212202). The "acceptance criteria" are implicitly met by showing that the differences between the proposed device and the predicate do not raise new questions of safety or effectiveness, which is supported by non-clinical testing.
The non-clinical testing performed includes evaluations of:
Acceptance Criteria Category (Implicit) | Reported Device Performance / Evaluation Type |
---|---|
Biocompatibility | Evaluated in accordance with ISO 10993-1 |
Sterilization | Validated in accordance with ISO 11135:2014 |
EO/ECH Residuals | Performed according to ISO 10993-7:2008 |
Shelf Life | Conducted based on ASTM F1980 |
Packaging Integrity | Evaluated in accordance with ISO 11607-1:2019 and ASTM F1980-16 |
Photobiological Safety | Performed based on IEC 62471:2006 (and stayed the same as K212202) |
Electrical Safety | Evaluated in accordance with IEC 60601-1 and IEC 60601-2-18 |
Electromagnetic Compatibility | Evaluated in accordance with IEC 60601-1-2 |
Optical and Color Performance | Resolution, Depth of Field, Distortion, Signal-to-Noise Ratio, Dynamic Range, Image/Brightness Uniformity, Color performance |
Note: For the Optical and Color Performance, the document lists the parameters tested but does not provide specific numerical acceptance criteria or reported performance values (e.g., "Resolution > X lp/mm" or "Distortion
Ask a specific question about this device
Page 1 of 1